ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Arcus Biosciences, Inc. (RCUS)

NYSE

$20.88

$+0.80

(+3.99%)

Arcus Biosciences, Inc. (RCUS) Live Price Chart

Page last updated: 2026-02-06 19:46:31

Key Market Data

Market Cap	$2.25B
Open	$20.60
High	$49.10
Low	$6.30
Previous Close	$20.03
Price Change	$+0.80
Percentage Change	+3.99%
Volume	389K

Arcus Biosciences, Inc. (RCUS) Stock Price Today

Arcus Biosciences, Inc. (RCUS) is currently trading at $20.88 as of 2026-02-06 19:46:31, reflecting a +3.99% move ($+0.80) from the previous close.

In the short term, the stock has returned -222.48% over the past four weeks. Over the last 12 months, Arcus Biosciences, Inc. has recorded a +60.45% price change, indicating a strong performance relative to the broader market.

Arcus Biosciences, Inc. (RCUS) 7-Day Stock Price Changes

Over the past seven days, Arcus Biosciences, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $21.00 to the latest recorded price of $20.88, reflecting an intraday change of +3.99%. Daily movements highlight shifts in trading volume (389,114), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, RCUS has delivered a -222.48% return over the past month and a +60.45% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Arcus Biosciences, Inc. (RCUS)

You can buy and trade RCUS on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for RCUS and Execute Your Trade

Open the trading page, enter RCUS in the search bar, select the amount of RCUS you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Arcus Biosciences, Inc. (RCUS)?

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Arcus Biosciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	674
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.arcusbio.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Arcus Biosciences, Inc.?

The latest trading price for Arcus Biosciences, Inc. (Common Stock) is $ 20.88, compared with a previous closing price of $ 20.03. That means the stock has moved +3.99% so far today. Intraday price updates and recent trading activity for RCUS can be tracked on the live chart and quote section on this page.

2.Is Arcus Biosciences, Inc. stock going up or down?

Looking at recent performances, RCUS has returned -222.48% over the past month, +127.89% over the last six months and +60.45% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Arcus Biosciences, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does RCUS currently sit relative to its 52-week high and low?

In the most recent 52-week period, Arcus Biosciences, Inc. has traded between a low of $ 6.50 and a high of $ 26.40. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether RCUS is currently nearer the top or the bottom of its one-year trading band.

4.How is Arcus Biosciences, Inc. classified by sector and industry?

Arcus Biosciences, Inc. is classified in the PHARMACEUTICAL PREPARATIONS sector, within the PHARMACEUTICAL PREPARATIONS industry group and the PHARMACEUTICAL PREPARATIONS industry. In practice, this means Arcus Biosciences, Inc. is grouped with companies that face similar end-markets, competitive dynamics and regulatory environments. For investors, knowing RCUS's sector and industry classification helps when building diversified portfolios, comparing Arcus Biosciences, Inc. with direct peers, and understanding how stock-specific risks such as -- may be influenced by broader trends in the PHARMACEUTICAL PREPARATIONS sector and PHARMACEUTICAL PREPARATIONS industry.

5.Where is Arcus Biosciences, Inc. listed and how large is it by market value?

Arcus Biosciences, Inc. is listed on the NYSE stock exchange in United States. Based on a market capitalization of $ 2.25B, the company is classified as a Mid-cap stock. Market cap gives a quick sense of Arcus Biosciences, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does RCUS's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -2.76 summarises how much profit Arcus Biosciences, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Arcus Biosciences, Inc.'s financial performance over time?

To follow Arcus Biosciences, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how RCUS is performing and how the market is responding.

8.When is Arcus Biosciences, Inc. expected to report earnings?

Arcus Biosciences, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for RCUS, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Arcus Biosciences, Inc.'s earnings reports?

Arcus Biosciences, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether RCUS is meeting, beating or missing expectations.

10.How can I stay informed about Arcus Biosciences, Inc.'s results and guidance?

You can stay up to date on Arcus Biosciences, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for RCUS on this page helps you see how new information is being reflected in the stock.

11.Does Arcus Biosciences, Inc. pay a regular cash dividend to its shareholders?

Arcus Biosciences, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor RCUS's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for RCUS?

Based on the latest earnings data, RCUS has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Arcus Biosciences, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Arcus Biosciences, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is RCUS valued in terms of P/E ratio and EPS?

Arcus Biosciences, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -2.76. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Arcus Biosciences, Inc.'s earnings. Comparing RCUS's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Arcus Biosciences, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

Allient Inc.

ALNT

Astec Industries Inc.

ASTE

Comstock Holding Companies, Inc.

CHCI

Emerson Electric Co.

EMR

Estrella Immunopharma, Inc.

ESLA

Top Gainers

Browse today's leading gainers in the US stock market

Bio Green Med Solution, Inc.

TuHURA Biosciences, Inc.

HURA

Liberty Global Ltd

LBTYB

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

RCUS-to-USD Calculator

Amount

RCUS

USD

1 RCUS = 20.875 USD